Bendayan D, Shitrit D, Ygla M, Huerta M, Fink G, Kramer M R
Pulmonary Institute, Rabin Medical Center, Petah-Tikva, Israel.
Respir Med. 2003 Feb;97(2):130-3. doi: 10.1053/rmed.2003.1440.
Pulmonary arterial hypertension is a malignant disease with a median survival of 3 years. Uric acid levels are elevated in severe heart failure and in states of hypoxemia. Early data suggest a correlation between hyperuricemia and severe pulmonary arterial hypertension. We studied 29 patients with pulmonary arterial hypertension diagnosed and treated between 1998 and 2001. Clinical characteristics (6 min walk test and New York Heart Association class) and hemodynamic parameters (pulmonary artery pressure, pulmonary vascular resistance and cardiac output) were evaluated and correlated to uric acid level in a retrospective study. Uric acid levels correlated positively with New York Heart Association class (r=0.66, P<0.001) and negatively with 6 min walk test (r=-0.35, P=0.03). Uric acid levels were higher in patients who died than in patients who survived at the end ofthe follow-up period (8.8 vs. 5.7 mg/dl, P=0.001). This study shows that uric acid levels are elevated in severe pulmonary arterial hypertension and can be used as a prognostic marker of disease severity.
肺动脉高压是一种恶性疾病,中位生存期为3年。严重心力衰竭和低氧血症状态下尿酸水平会升高。早期数据表明高尿酸血症与严重肺动脉高压之间存在关联。我们研究了1998年至2001年间诊断并接受治疗的29例肺动脉高压患者。在一项回顾性研究中,对临床特征(6分钟步行试验和纽约心脏协会分级)和血流动力学参数(肺动脉压、肺血管阻力和心输出量)进行了评估,并与尿酸水平进行了关联分析。尿酸水平与纽约心脏协会分级呈正相关(r=0.66,P<0.001),与6分钟步行试验呈负相关(r=-0.35,P=0.03)。随访期末死亡患者的尿酸水平高于存活患者(8.8 vs. 5.7 mg/dl,P=0.001)。这项研究表明,严重肺动脉高压患者的尿酸水平升高,可作为疾病严重程度的预后标志物。